MALPEZZI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 1.713
EU - Europa 1.230
NA - Nord America 1.075
SA - Sud America 185
AF - Africa 24
OC - Oceania 7
Totale 4.234
Nazione #
US - Stati Uniti d'America 1.037
CN - Cina 686
SG - Singapore 480
IT - Italia 460
HK - Hong Kong 167
DE - Germania 164
BR - Brasile 151
GB - Regno Unito 117
SE - Svezia 116
KR - Corea 100
RU - Federazione Russa 75
VN - Vietnam 75
FR - Francia 50
ID - Indonesia 47
FI - Finlandia 42
ES - Italia 38
JP - Giappone 31
NL - Olanda 29
BE - Belgio 27
CA - Canada 26
IN - India 22
CH - Svizzera 19
LT - Lituania 19
PL - Polonia 16
IR - Iran 14
BD - Bangladesh 13
AR - Argentina 12
IE - Irlanda 11
IQ - Iraq 11
MY - Malesia 10
TW - Taiwan 10
AT - Austria 9
CZ - Repubblica Ceca 9
EC - Ecuador 8
TR - Turchia 8
ZA - Sudafrica 8
CL - Cile 7
MX - Messico 7
PH - Filippine 7
SA - Arabia Saudita 6
AU - Australia 5
UZ - Uzbekistan 5
LI - Liechtenstein 4
PT - Portogallo 4
HU - Ungheria 3
KE - Kenya 3
KZ - Kazakistan 3
MA - Marocco 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
PK - Pakistan 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
UA - Ucraina 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
IL - Israele 2
NZ - Nuova Zelanda 2
RO - Romania 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BY - Bielorussia 1
CO - Colombia 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
NP - Nepal 1
PE - Perù 1
UY - Uruguay 1
VE - Venezuela 1
Totale 4.234
Città #
Hefei 379
Santa Clara 325
Singapore 320
Hong Kong 160
Ashburn 145
Seoul 87
Modena 73
London 63
Frankfurt am Main 62
Beijing 53
Los Angeles 42
Jakarta 38
Munich 38
New York 34
Nyköping 33
Milan 32
Ho Chi Minh City 31
Bologna 30
Chandler 26
Helsinki 23
Reggio Emilia 22
Kent 21
The Dalles 21
Moscow 20
Parma 20
Boardman 19
Shanghai 19
Hanoi 17
Padova 17
Buffalo 16
Leuven 15
Hangzhou 14
Warsaw 14
Dallas 13
Decatur 13
Barcelona 12
São Paulo 12
Amsterdam 11
Lappeenranta 11
Rome 10
Tehran 10
Brussels 9
Chicago 9
Madrid 9
Zurich 9
Boston 8
Brooklyn 8
Chennai 8
Dublin 8
Formigine 8
Manchester 8
Nuremberg 8
Phoenix 8
Tokyo 8
Argenta 7
Denver 7
Kuala Lumpur 7
Montreal 7
Orem 7
Ottawa 7
Poplar 7
Atlanta 6
Brno 6
Charlotte 6
East Wenatchee 6
Lauterbourg 6
Leipzig 6
Osnabrück 6
Princeton 6
Rossdorf 6
Santiago 6
Turku 6
Vienna 6
Washington 6
Ankara 5
Belo Horizonte 5
Cebu City 5
Ferrara 5
Guangzhou 5
Hillsboro 5
Mexico City 5
Piacenza 5
Portsmouth 5
Raleigh 5
Rio de Janeiro 5
San Diego 5
Seattle 5
Turin 5
Assago 4
Bomporto 4
Brasília 4
Casalgrande 4
Chongqing 4
Council Bluffs 4
Düsseldorf 4
Florence 4
Ispra 4
Marseille 4
Paris 4
Quito 4
Totale 2.674
Nome #
Designing selective Cys-ligands to unpair the binding of the Human Transcription Enhancer Associated Domain 4 (hTEAD-4) with its modulators to halt cancer cell growth 241
Exploiting Forster Resonance Energy Transfer (FRET) in the characterization of YAP:TEAD complex disruption 219
design, synthesis and biological evaluation of novel YAP:TEAD complex disruptors for thetreatment of colorectal cancer 200
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma 191
A toolbox of biophysical and analytical assays helps to confirm the activity of novel hTS dimer disrupters (Ddis) with anticancer properties 189
Applying optical tweezers technology to reveal Thymidylate Synthase interactions with its consensus mRNA 181
Current Treatments to Control African Trypanosomiasis and One Health Perspective 177
UHPLC-MS/MS screening of the hTEAD surface for the identification of novel allosteric inhibitors with anticancer activity 154
Lead optimization of human thymidylate synthase dimer disrupters: from computational studies to evaluation of their biological profiles 153
Lead-optimization process and characterization of the dissociative effect applied to new dimer disrupters of human Thymidylate Synthase 153
Exploring thymidylate synthase mRNA binding site 1 and human TS protein interaction with optical tweezers and bicistronic expression assay 146
Leveraging proteomic, bioinformatic and ecotoxicology models to select new targets overcoming L. Infantum drug resistent 143
Advancing sustainable drug development: comparative preclinical study of H80 and Miltefosine using imaging and proteomics 140
LC-MS/MS proteomics for the rapid and selective screening of drug resistances in Leishmania infantum clinical isolates 138
Exploiting the Optical Tweezer technology to reveal thymidylate synthase interactions with its consensus mRNA 137
EXPLOITING THE OPTICAL TWEEZER, A SINGLE MOLECULE TECHNOLOGY, TO REVEAL THYMIDYLATE SYNTHASE INTERACTIONS WITH ITS CONSENSUS mRNA 136
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 136
Insights into host-target interaction from the proteome modulation analysis through untargeted LC-MS/MS Proteomics of drug resistant L infantum-THP1 infected cells 132
Deciphering Host–Parasite Interplay in Leishmania Infection through a One Health View of Proteomics Studies on Drug Resistance 130
Optimization of chemical-biological tools for characterizing the activity of dissociative inhibitor of human thymidylate synthase 125
Optical tweezers to investigate at the single-molecule level the interaction of thymidylate synthase with its consensus mRNA 123
One Health Approach in Drug Discovery for Leishmaniasis by Targeting Calpain cys-protease. 123
Investigating the mechanism of action of the antiparasitic agent H80 through imaging techniques 119
Leveraging proteomics, bioinformatics, and ecotoxicology models to select new targets overcoming L infantum drug resistance. 107
MS Proteomics And Biochemical Characterization Of Thymidylate Synthase Dimer Destabilizer E7 To Halt Colorectal Carcinoma 105
Drug discovery of pyrazolo-piperidinone inhibitors targeting YAP:TEAD interaction and development of a fluorescence anisotropy assay for high-throughput screening 101
Targeting of the Cysteines Surface domain of the Transcriptional Enhancer Associate Domain (TEAD) for anticancer drug discovery 100
Promoting A Sustainable Medicinal Chemistry Approach With The Cost Action CA21111 - One Health Drugs Against Parasitic Vector Borne Diseases In Europe And Beyond 96
Preclinical investigation of H80 compared to miltefosine: imaging and proteomics for sustainable drug development 82
Development of a fluorescent anisotropy displacement assay for the optimization of YAP:TEAD molecular disrupters with anticancer activity 54
IDENTIFICATION OF PYRAZOLO-PIPERIDINONE DERIVATIVES TARGETING YAP-TEAD INTERFACE 3 AS ANTICANCER AGENTS THROUGH INTEGRATED VIRTUAL SCREENING AND MASS SPECTROMETRY PROTEOMICS 37
Totale 4.268
Categoria #
all - tutte 15.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 0 0 0 17 9 6 12 4 22 13
2022/2023272 35 23 14 18 13 20 18 35 50 1 31 14
2023/2024651 38 43 47 28 146 38 65 54 16 9 98 69
2024/20251.723 55 33 64 101 290 252 135 89 169 70 249 216
2025/20261.539 252 209 284 353 322 119 0 0 0 0 0 0
Totale 4.268